Specifications
- Product name
- NeoPlex™ HPV29 Detection
- Targets
-
High-risk HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 67, 68, 69, 70, 73, 82 (21 types)
Low-risk HPV 6, 11, 40, 42, 43, 44, 54, 61 (8 types)
- Specimens
- Liquid based cytology
- Compatible instruments
- CFX96™ Dx System (Bio-Rad)
- Fluorophores
- FAM / HEX / Cal Red 610 / Quasar 670 / Quasar 705
Ease of use
- Technology
-
Single-tube Multiplex Real-time PCR (C-Tag™ )
- TAT
-
Within 2.5 hours of analysis after nucleic acid extraction
- UDG System
-
Yes
- Internal Control
-
Endogenous
Clinical performance
- Clinical Sensitivity
-
98.02 - 100%
- Clinical Specificity
-
99.73 - 100%
- Reproducibility
-
100%
Ordering Information
Request for quotation| Cat. No. | Product | Description | Method | Size |
|---|---|---|---|---|
| NS02A | NeoPlex™ HPV29 Detection |
Simultaneous Detection and Genotyping of 29 HPV types | Multiplex Real-time PCR | 96 Tests/Kit |
| NS02B | NeoPlex™ HPV29 Detection |
Simultaneous Detection and Genotyping of 29 HPV types | Multiplex Real-time PCR | 50 Tests/Kit |
Related products
-
NeoPlex™ HPV HR DetectionSimultaneous Detection and Genotyping of 14 High-risk HPV Genotypes
Explore Product
